EMA safety committee ramps up warning against use of topiramate during pregnancy
The European Medicines Agency’s safety committee has issued a new warning against using topiramate, a drug commonly used to treat epilepsy and migraines, during pregnancy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.